SCHEMBL31501508

SCHEMBL31501508

O=C(O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CTRB1 P17538 1/20 0.46
▸ PREP P48147 4/20 0.43
▸ F2 P00734 2/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ MDM4 O15151 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ FDFT1 P37268 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29777655 1.00 CTRB1 (0.46) CTRB1PREPF2KMT2AMDM4
SCHEMBL29749447 0.96 CTRB1 (0.48) CTRB1F2KMT2AMDM4TP53
SCHEMBL30688537 0.88 CTRB1 (0.44) CTRB1F2KMT2AFDFT1NPSR1
SCHEMBL8902887 0.88 CTRB1 (0.46) CTRB1PREPF2KMT2ANPSR1
SCHEMBL29706288 0.88 CTRB1 (0.55) CTRB1F2KMT2AMDM4TP53
SCHEMBL6434028 0.87 CTRB1 (0.56) CTRB1F2KMT2A
SCHEMBL29868206 0.87 CTRB1 (0.56) CTRB1F2KMT2A
SCHEMBL29566581 0.86 CTRB1 (0.46) CTRB1F2KMT2AMDM4TP53
SCHEMBL29858987 0.86 CTRB1 (0.46) CTRB1F2KMT2AMDM4TP53
SCHEMBL29467321 0.85 F2 (0.45) PREPF2KMT2AMDM4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119978100-A Tizepa Process for producing peptide 四川吉晟生物医药有限公司 2025-05-13 — — CN disclosed
CN-119529056-A Solid phase preparation method of telipopeptide 福建基诺厚普生物科技有限公司 2025-02-28 — — CN disclosed
Send feedback